|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/18 | |
| C12Q 1/04 | |||
| G01N 33/94 |
| (11) | Number of the document | 2737077 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12817566.8 |
| Date of filing the European patent application | 2012-07-26 | |
| (97) | Date of publication of the European application | 2014-06-04 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/048329 |
| Date | 2012-07-26 |
| (87) | Number | WO 2013/016529 |
| Date | 2013-01-31 |
| (30) | Number | Date | Country code |
| 201161511608 P | 2011-07-26 | US | |
| 201261642099 P | 2012-05-03 | US |
| (72) |
BELLEY, Adam, CA
|
| (73) |
The Medicines Company,
8 Sylvan Way, Parsippany, NJ 07054,
US
|
| (54) | DISK DIFFUSION ASSAY FOR ORITAVANCIN |
| DISK DIFFUSION ASSAY FOR ORITAVANCIN |